Soon after the pandemic began, India's government tasked the country's most advanced bioscience innovation hub — the publicly funded Centre for Cellular and Molecular Platforms, or C-CAMP — with quickly finding a way to locally produce virus test kits and their components. Over a year later, most Indians can access PCR tests at a fraction of the cost — representing a massive effort by a public-private partnership to set up the local expertise to manufacture these tests within India at a low price.